For research use only
| Cat No. | ABC-TC0423 |
| Product Type | Human Lymphoma Cell Lines |
| Cell Type | Lymphoblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Burkitt’s Lymphoma |
| Product Code | Hs-Sultan; HS-SULTAN; HS-sultan; HS Sultan; HSSultan; H. S. Sultan; SULTAN; Sultan |
Probe HS-Sultan Human Burkitt’s Lymphoma cells for lymphoma pathogenesis modeling, drug screening, and B-cell signaling analysis using JIYOYE subclone.
HS-Sultan is a human hematopoietic tumor cell line originally established from blood cells thought to represent a plasmacytoma but later confirmed to be a derivative of the Burkitt lymphoma Jiyoye lineage via DNA fingerprinting. It grows as suspension lymphoblasts with a modal hyperdiploid karyotype (modal chromosome number ~48), and expresses typical B-cell surface markers and immunoglobulin kappa light chains, consistent with lymphoid lineage characteristics. HS-Sultan cell line has also been used in research evaluating drug-resistance phenotypes in Burkitt lymphoma derivatives, demonstrating its utility in oncology studies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Hs-Sultan; HS-SULTAN; HS-sultan; HS Sultan; HSSultan; H. S. Sultan; SULTAN; Sultan |
| Species | Human |
| Cat.No | ABC-TC0423 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphoblast |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Blood |
| Disease | Burkitt’s Lymphoma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Lymphoma Cell Lines |
HS-Sultan cells are employed as an in vitro human Burkitt lymphoma model for studies of lymphoid tumor proliferation, cell signaling, and chemotherapeutic responses. They are particularly useful in drug sensitivity and resistance assays and investigations of molecular mechanisms underlying lymphoma cell survival and therapeutic resistance.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
